HOOK: Rega marang dodolan HOOKIPA Pharma, Inc.
The current P/S of HOOKIPA Pharma Inc. (HOOK) demonstrates volatility dependent on the scalability of biocomponents and successes in cancer therapy. The 0.90 indicator determines the magnitude of the metric, while capitalization is based on payments from Gilead for vaccines. Business stability is supported by diversified air transport, which prevents supply disruptions of medications for patients with HIV and hepatitis.
Rincian metrik lan analitis perusahaan HOOKIPA Pharma Inc. (HOOK)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal HOOKIPA Pharma Inc.|HOOK - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal hookipapharma.com|HOOK - Gunggung utang perusahaan|Utang-utang marang aset resik HOOKIPA|HOOK - Utang jangka dawa perusahaan|Kewajiban jangka cendhak HOOKIPA Pharma|Rasio cepet hookipapharma.com
- informasi bathi lan kelipatan valuasi:
HOOK - Penghasilan resik|Penghasilan resik sing dikarepake HOOKIPA Pharma Inc.|HOOK - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake hookipapharma.com|HOOK - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan HOOKIPA|HOOK - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) HOOKIPA Pharma|HOOK - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan hookipapharma.com|HOOK - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep HOOKIPA Pharma Inc.
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:HOOK, HOOKIPA Pharma, Inc.
The strong pricing power of HOOKIPA Pharma Inc. (HOOK) within the HPV tumor therapy segment renders revenue resilient to market volatility, which is critical for assessing capitalization via the P/S multiple. By analyzing the divergence of the P/S ratio from its historical average, an investor compares the business's market value with the volume of generated revenue to determine the premium paid for unique virus reprogramming technologies and capital liquidity.
Pesaing HOOKIPA Pharma Inc.
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan PTGX (Protagonist Corp)|Immunovant, Inc. (IMVT) - Rasio rega marang pendapatan|Rega marang dodolan kiniksa.com (KNSA)|Rasio rega marang pendapatan Grifols|Rega marang dodolan Adaptive Biotech ADPT|Rasio rega marang pendapatan Celldex (CLDX)|Multiplikator P/S Aurinia Corp (AUPH)|Multiplikator P/S BCRX (BioCryst)|Koefisien rega marang pendapatan veratx.com (VERA)|DNTH - Rasio rega marang pendapatan|Rasio rega marang dodolan PHVS|ABCL: Multiplikator P/S|Tourmaline (TRML) - Multiplikator P/S|Kapitalisasi marang pendapatan PGEN|PHAR: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Nektar Therapeutics Inc. (NKTR)|UPB: Rasio rega marang dodolan|Multiplikator P/S ZBIO (Zenas Biopharma, Inc.)|Rasio kapitalisasi pasar marang pendapatan IMNM|Gossamer Bio, Inc. - Multiplikator P/S|KALV - Multiplikator P/S|Septerna (SEPN) - Rasio rega marang pendapatan|Pieris Pharma - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Savara Corp|Kapitalisasi marang pendapatan Rigel Corp (RIGL)|Multiplikator P/S ANAB|Multiplikator P/S astriatx.com (ATXS)|enGene - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan RAPT|Aerovate - Multiplikator P/S|Koefisien rega marang pendapatan Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics (KYTX) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan TLSA|CABA (Cabaletta Bio) - Multiplikator P/S|Kapitalisasi marang pendapatan Ventyx Biosciences Inc. (VTYX)|Kapitalisasi marang pendapatan THTX (Theratechnologies Inc)|Koefisien rega marang pendapatan Avalo Therapeutics Inc|Multiplikator P/S ELDN (Eledon Pharmaceuticals)|Rasio kapitalisasi pasar marang pendapatan AGEN|CLYM - Rasio rega marang pendapatan|Rega marang dodolan Zura Bio Ltd|aTyr (ATYR) - Rasio rega marang pendapatan|Rega marang dodolan Adagene Inc. (ADAG)|Rasio rega marang pendapatan ImageneBio|Multiplikator P/S Shattuck Therapeutics|Rasio rega marang pendapatan Equillium, Inc. (EQ)|CNTB: Rasio rega marang dodolan|Multiplikator P/S IMUX (Immunic)|Rasio kapitalisasi pasar marang pendapatan ATRA|InflaRx GmbH - Multiplikator P/S|XFOR - Multiplikator P/S|adicetbio.com (ACET) - Rasio rega marang pendapatan|Celularity - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan INmune Bio Corp|Kapitalisasi marang pendapatan Barinthus Biotherapeutics Corp (BRNS)|Multiplikator P/S KZR|Multiplikator P/S sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ENLV|Q32 Bio Corp - Multiplikator P/S|Koefisien rega marang pendapatan GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ibioinc.com|Rasio rega marang pendapatan Carisma Therapeutics Inc|Kapitalisasi marang pendapatan XTL Biopharmaceuticals Ltd (XTLB)|Kapitalisasi marang pendapatan BOLT (Bolt Biotherapeutics)|Multiplikator P/S hcwbiologics.com (HCWB)|Rasio rega marang pendapatan Aptevo Therapeutics Inc. APVO|AIM: Rasio kapitalisasi marang pendapatan|Aditxt Corp - Multiplikator P/S|Rega marang dodolan GRI Bio Inc|XRTX: Multiplikator P/S|Vyome Therapeutics - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Revelation Biosciences|Rega marang dodolan indaptusrx.com INDP|Rasio rega marang pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Rega marang dodolan|Rasio rega marang pendapatan Affimed N.V. AFMD|Multiplikator P/S Allakos Inc ALLK|IGM Bio - Multiplikator P/S|Koefisien rega marang pendapatan iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Rasio rega marang pendapatan|Rasio rega marang dodolan TCBP (TC BioPharm (Holdings) Plc)|THRD (Third Harmonic Bio, Inc) - Multiplikator P/S
